Brachytherapy in the Management of Prostate Cancer

被引：21
作者：
Stish, Bradley J. [1 ]
Davis, Brian J. [1 ]
Mynderse, Lance A. [2 ]
Deufel, Christopher L. [1 ]
Choo, Richard [1 ]
机构：
[1] Mayo Clin, Dept Radiat Oncol, 200 First St Southwest, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Urol, 200 First St Southwest, Rochester, MN 55905 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2017年 / 26卷 / 03期
关键词：
Prostate cancer; High dose rate brachytherapy; Low dose rate brachytherapy; Radiation therapy; Image guidance; Dose escalation; HIGH-DOSE-RATE; EXTERNAL-BEAM RADIATION; QUALITY-OF-LIFE; ANDROGEN-DEPRIVATION THERAPY; RADIOACTIVE-SEED IMPLANTATION; SOCIETY CONSENSUS GUIDELINES; LONG-TERM; INTERSTITIAL BRACHYTHERAPY; EXTRAPROSTATIC EXTENSION; AMERICAN-BRACHYTHERAPY;
D O I：
10.1016/j.soc.2017.01.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Brachytherapy is performed by directly inserting radioactive sources into the prostate gland and is an important treatment option for appropriately selected men with prostate adenocarcinoma. Brachytherapy provides highly conformal radiotherapy and delivers tumoricidal doses that exceed those administered with external beam radiation therapy. There is a significant body of literature supporting the excellent long-term oncologic and safety outcomes achieved when brachytherapy is used for men in all risk categories of nonmetastatic prostate cancer. This article highlights some important considerations and published outcomes that relate to brachytherapy and its role in the treatment of prostate cancer.
引用
收藏
页码：491 / 513
页数：23
相关论文
共 149 条
  • [1] Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy
    Aaronson, David S.
    Yamasaki, Ichiro
    Gottschalk, Alexander
    Speight, Joycelyn
    Hsu, I-Chow
    Pickett, Barby
    Roach, Mack, III
    Shinohara, Katsuto
    [J]. BJU INTERNATIONAL, 2009, 104 (05) : 600 - 604
  • [2] Dosimetry Modeling for Focal Low-Dose-Rate Prostate Brachytherapy
    Al-Qaisieh, Bashar
    Mason, Josh
    Bownes, Peter
    Henry, Ann
    Dickinson, Louise
    Ahmed, Hashim U.
    Emberton, Mark
    Langley, Stephen
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (04): : 787 - 793
  • [3] Monte Carlo dosimetry of a new 192Ir high dose rate brachytherapy source
    Angelopoulos, A
    Baras, P
    Sakelliou, L
    Karaiskos, P
    Sandilos, P
    [J]. MEDICAL PHYSICS, 2000, 27 (11) : 2521 - 2527
  • [4] Biochemical outcomes for patients with intermediate risk prostate cancer treated with I-125 interstitial brachytherapy monotherapy
    Anna Thi Huyen Tran
    Mandall, Paula
    Swindell, Ric
    Hoskin, P. J.
    Bottomley, David Martin
    Logue, John Paul
    Wylie, James Pinson
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 109 (02) : 235 - 240
  • [5] [Anonymous], AM J CLIN ONCOL CANC
  • [6] [Anonymous], 1985, DOS VOL SPEC REP INT
  • [7] [Anonymous], EUR UROL
  • [8] [Anonymous], 2016, NCCN CLIN PRACTICE G
  • [9] ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer
    Ash, D
    Flynn, A
    Battermann, J
    de Reijke, T
    Lavagnini, P
    Blank, L
    [J]. RADIOTHERAPY AND ONCOLOGY, 2000, 57 (03) : 315 - 321
  • [10] From whole gland to hemigland to ultra-focal high-dose-rate prostate brachytherapy: A dosimetric analysis
    Banerjee, Robyn
    Park, Sang-June
    Anderson, Erik
    Demanes, D. Jeffrey
    Wang, Jason
    Kamrava, Mitchell
    [J]. BRACHYTHERAPY, 2015, 14 (03) : 366 - 372
12345678910